Publications

Division/Center

Instrumental variable analyses for observational comparative effectiveness research: the paired availability design.

Ann. Intern. Med.
Garabedian LF, Zaslavsky AM, Soumerai SB

Implementing large-scale programmes to optimise the health workforce in low- and middle-income settings: a multicountry case study synthesis.

Trop Med Int Health
Gopinathan U, Lewin S, Glenton C.

Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison.

J Clin Pharm Ther
Kelly E, Lu CY, Albertini S, Vitry A

National trends and disparities in cervical cancer screening among commercially insured Women, 2001-2010.

Cancer Epidemiol. Biomarkers Prev.
Wharam JF, Zhang F, Xu X, Landon BE, Ross-Degnan D

Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.

Med Care
Naci H, Soumerai SB, Ross-Degnan D, Zhang F, Briesacher BA, Gurwitz JH, Madden JM

Authors' reply to Mosholder and colleagues.

BMJ
Lu CY, Simon G, Soumerai SB

Development of a novel, objective measure of health care-related financial burden for U.S. families with children.

Health Serv Res
Wisk LE, Gangnon R, Vanness DJ, Galbraith AA, Mullahy J, Witt WP

Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis.

Int. J. Clin. Pract.
Hsu JC, Tang DH, Lu CY

Authors' reply to Olfson and Schoenbaum, Nardo, Bartlett, Moore, Case, Gøtzsche, and Barber and colleagues.

BMJ
Lu CY, Simon G, Soumerai SB

Behavioral health services following implementation of screening in Massachusetts Medicaid children.

Pediatrics
Hacker KA, Penfold RB, Arsenault LN, Zhang F, Murphy M, Wissow LS

Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

J. Natl. Cancer Inst.
Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O, Berry DA, Burnside ES, Chang Y, Chisholm G, de Koning HJ, Ali Ergun M, Heijnsdijk EA, Huang H, Stout NK, Sprague BL, Trentham-Dietz A, Mandelblatt JS, Plevritis SK

Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.

Health Policy Plan
Vialle-Valentin CE, Serumaga B, Wagner AK, Ross-Degnan D

Health insurance coverage and the receipt of specialty treatment for substance use disorders among U.S. adults

Psychiatr Serv
Cummings JR, Wen H, Ritvo A, Druss BG

Quality use of medicines within universal health coverage: challenges and opportunities.

BMC Health Serv Res
Wagner AK, Quick JD, Ross-Degnan D

Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions.

Health Aff (Millwood)
Naci H, Soumerai SB, Ross-Degnan D, Zhang F, Briesacher BA, Gurwitz JH, Madden JM

Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage.

Med Care
Adams AS, Madden JM, Zhang F, Soumerai SB, Gilden D, Griggs J, Trinacty CM, Bishop C, Ross-Degnan D

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses.

Int J Equity Health
Leopold C, Zhang F, Mantel-Teeuwisse AK, Vogler S, Valkova S, Ross-Degnan D, Wagner AK

Effect of Massachusetts health reform on chronic disease outcomes.

Health Serv Res
Stryjewski TP, Zhang F, Eliott D, Wharam JF

Potential bias of instrumental variable analyses for observational comparative effectiveness research.

Ann. Intern. Med.
Garabedian LF, Chu P, Toh S, Zaslavsky AM, Soumerai SB

National prevalence of receipt of antidepressant prescriptions by persons without a psychiatric diagnosis.

Psychiatr Serv
Simon GE, Stewart C, Beck A, Ahmedani BK, Coleman KJ, Whitebird RR, Lynch F, Owen-Smith AA, Waitzfelder BE, Soumerai SB, Hunkeler EM